Subcutaneous microdialysis before and after an oral glucose tolerance test: A method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus

Diabetes, Obesity and Metabolism

Volumn 7, Issue 5, 2005, Pages 525-535

  Rajamand, Neda ^a   Ungerstedt, U ^a   Brismar, K ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adipose tissue; Diabetes mellitus; Human; Insulin resistance; Insulin like growth factor binding protein 1; Microdialysis

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; GLYCEROL; INSULIN; INSULIN LISPRO; ISOPHANE INSULIN; LACTIC ACID; METFORMIN; ORAL ANTIDIABETIC AGENT; PYRUVIC ACID; SOMATOMEDIN BINDING PROTEIN 1;

ADIPOSE TISSUE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HUMAN; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOLYSIS; MICRODIALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PATIENT MONITORING; SUBCUTANEOUS TISSUE;

EID: 23844497457     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2004.00424.x     Document Type: Article

References (40)

1. Ungerstedt U. Microdialysis - principles and applications for studies in animals and man. J Intern Med 1991; 230 (4): 365-373.
2. Jungheim K, Wientjes KJ, Heinemann L, Lodwig V, Koschinsky T, Schoonen AJ. Subcutaneous continuous glucose monitoring: feasibility of a new microdialysis-based glucose sensor system. Diabetes Care 2001; 24 (9): 1696-1697.
3. Bolinder J, Ungerstedt U, Arner P. Long-term continuous glucose monitoring with microdialysis in ambulatory insulin-dependent diabetic patients. Lancet 1993; 342 (8879): 1080-1085.
4. Stumvoll M, Gerich J. Clinical features of insulin resistance and beta cell dysfunction and the relationship to type 2 diabetes. Clin Lab Med 2001; 21 (1): 31-51.
5. Yki-Jarvinen H, Koivisto VA. Natural course of insulin resistance in type I diabetes. N Engl J Med 1986; 315 (4): 224-230.
6. Yki-Jarvinen H. Glucose toxicity. Endocr Rev 1992; 13 (3): 415-431.
7. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28 (7): 412-419.
8. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237 (3): E214-E223.
9. Stumvoll M, Mitrakou A, Pimenta W et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000; 23 (3): 295-301.
10. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22 (9): 1462-1470.
11. Brismar K, Hilding A, Lindgren B. Regulation of IGFBP-1 in humans. Prog Growth Factor Res 1995; 6 (2-4): 449-456.
12. Lee PD, Giudice LC, Conover CA, Powell DR. Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med 1997; 216 (3): 319-357.
13. Rajkumar K, Murphy LJ. Enhanced gluconeogenesis and hepatic insulin resistance in insulin-like growth factor binding protein-1 transgenic mice. Biochim Biophys Acta 1999; 1426 (3): 491-497.
14. Mauvais-Jarvis F, Kahn CR. Understanding the pathogenesis and treatment of insulin resistance and type 2 diabetes mellitus: what can we learn from transgenic and knockout mice? Diabetes Metab. 2000; 26 (6): 433-448.
15. Stumvoll M, Jacob S. Multiple sites of insulin resistance: muscle, liver and adipose tissue. Exp Clin Endocrinol Diabetes 1999; 107 (2): 107-110.
16. Hagstrom-Toft E, Enoksson S, Moberg E, Bolinder J, Arner P. Absolute concentrations of glycerol and lactate in human skeletal muscle, adipose tissue, and blood. Am J Physiol 1997; 273 (3 Pt 1): E584-E592.
17. Rosdahl H, Hamrin K, Ungerstedt U, Henriksson J. Metabolite levels in human skeletal muscle and adipose tissue studied with microdialysis at low perfusion flow. Am J Physiol 1998; 274 (5 Pt 1): E936-E945.
18. Bolinder J, Ungerstedt U, Arner P. Microdialysis measurement of the absolute glucose concentration in subcutaneous adipose tissue allowing glucose monitoring in diabetic patients. Diabetologia 1992; 35 (12): 1177-1180.
19. Hagstrom-Toft E, Hellstrom L, Moberg E. Lipolytic response during spontaneous hypoglycaemia in insulin-dependent diabetic subjects. Horm Metab Res 1998; 30 (9): 586-593.
20. Hagstrom-Toft E, Bolinder J, Ungerstedt U, Arner P. A circadian rhythm in lipid mobilization which is altered in IDDM. Diabetologia 1997; 40 (9): 1070-1078.
21. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20 (7): 1183-1197.
22. Povoa G, Roovete A, Hall K. Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinologica 1984; 107: 63-570.
23. Bang Peter EU, Sara V, Wivall I-L, Hall K. Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinologica 1991; 124: 620-629.
24. Hilding A, Brismar K, Degerblad M, Thoren M, Hall K. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. J Clin Endocrinol Metab 1995; 80 (9): 2646-2652.
25. Albareda M, Rodriguez-Espinosa J, Murugo M, de Leiva A, Corcoy R. Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 2000; 43 (12): 1507-1511.
26. Lovejoy J, Mellen B, Digirolamo M. Lactate generation following glucose ingestion: relation to obesity, carbohydrate tolerance and insulin sensitivity. Int J Obes 1990; 14 (10): 843-855.
27. Jansson PA, Larsson A, Smith U, Lonnroth P. Lactate release from the subcutaneous tissue in lean and obese men. J Clin Invest 1994; 93 (1): 240-246.
28. Wisniewski N, Rajamand N, Adamsson U et al. Analyte flux through chronically implanted subcutaneous polyamide membranes differs in humans and rats. Am J Physiol Endocrinol Metab 2002; 282 (6): E1316-E1323.
29. Hagstrom E, Arner P, Ungerstedt U, Bolinder J. Subcutaneous adipose tissue: a source of lactate production after glucose ingestion in humans. Am J Physiol 1990; 258 (5 Pt 1): E888-E893.
30. Hagstrom-Toft E. Microdialysis for the assessment of catecholamine-induced lipolysis in adipose and skeletal muscle tissue. Adv Pharmacol 1998; 42: 634-638.
31. Kerckhoffs DA, Arner P, Bolinder J. Lipolysis and lactate production in human skeletal muscle and adipose tissue following glucose ingestion. Clin Sci (Lond) 1998; 94 (1): 71-77.
32. Yki-Jarvinen H, Kubo K, Zawadzki J et al. Dissociation of in vitro sensitivities of glucose transport and antilipolysis to insulin in NIDDM. Am J Physiol 1987; 253 (3 Pt 1): E300-E304.
33. van der Merwe TM, Eklund L, Jansson PA, Lonnroth PN. Effects of hyperglycemia on in vivo adipose tissue metabolism studied with microdialysis in IDDM subjects. Diabetes 1994; 43 (7): 866-870.
34. Ekman B, Nystrom F, Arnqvist HJ. Circulating IGF-I concentrations are low and not correlated to glycaemic control in adults with type 1 diabetes. Eur J Endocrinol 2000; 143 (4): 505-510.
35. Nurjhan N, Consoli A, Gerich J. Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus. J Clin Invest 1992; 89 (1): 169-175.
36. Enoksson S, Talbot M, Rife F, Tamborlane WV, Sherwin RS, Caprio S. Impaired in vivo stimulation of lipolysis in adipose tissue by selective beta2-adrenergic agonist in obese adolescent girls. Diabetes 2000; 49 (12): 2149-2153.
37. Jansson PA, Fowelin JP, von Schenck HP, Smith UP, Lonnroth PN. Measurement by microdialysis of the insulin concentration in subcutaneous interstitial fluid. Importance of the endothelial barrier for insulin. Diabetes 1993; 42 (10): 1469-1473.
38. van der Merwe MT, Schlaphoff GP, Crowther NJ et al. Lactate and glycerol release from adipose tissue in lean, obese, and diabetic women from South Africa. J Clin Endocrinol Metab 2001; 86 (7): 3296-3303.
39. Frystyk J, Grofte T, Skjaerbaek C, Orskov H. The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults. J Clin Endocrinol Metab 1997; 82 (9): 3124-3127.
40. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 1994; 79 (3): 872-878.